Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015–2018 Years

BACKGROUND: In Poland drug programmes developed by the Minister of Health and financed by the National Health Fund are special reimbursement frameworks of innovative, expensive, and mostly hospital based medical products used for a small number of patients. RESEARCH DESIGN: The research presented in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Mela, Aneta, Poniatowski, Łukasz A., Drop, Bartłomiej, Furtak-Niczyporuk, Marzena, Jaroszyński, Janusz, Wrona, Witold, Staniszewska, Anna, Dąbrowski, Jan, Czajka, Anna, Jagielska, Beata, Wojciechowska, Monika, Niewada, Maciej
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7456857/
https://ncbi.nlm.nih.gov/pubmed/32922285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01123
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars